Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02328937 · ClinicalTrials.gov registry record · NA
Central Corneal Swelling With Silicone Hydrogel Materials
A NA study of Corneal Swelling, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT02328937 is a NA study of Corneal Swelling that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 41 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02328937, a NA study of Corneal Swelling, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, single site, unmasked, cross-over study with three silicone hydrogel contact lenses comparing central corneal swelling.
Conditions Studied
Interventions
- DEVICE lotrafilcon B
- DEVICE etafilcon A
- DEVICE comfilcon A
Study Locations (1)
Ohio
- - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02328937
The ClinicalTrials.gov registry entry for NCT02328937 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Corneal Swelling appearing as the primary indexed condition, and to 3 interventions - of which lotrafilcon B is the first listed.
NCT02328937 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02328937 about?
NCT02328937 is a clinical study titled "Central Corneal Swelling With Silicone Hydrogel Materials". This is a prospective, single site, unmasked, cross-over study with three silicone hydrogel contact lenses comparing central corneal swelling.
What is the current status of trial NCT02328937?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2014-11. Estimated completion is 2015-04.
What conditions does trial NCT02328937 study?
This clinical trial studies the following conditions: Corneal Swelling.
What interventions are being tested in trial NCT02328937?
The interventions under investigation include: lotrafilcon B (DEVICE), etafilcon A (DEVICE), comfilcon A (DEVICE).
Who is sponsoring clinical trial NCT02328937?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02328937 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.